Skip to search formSkip to main contentSkip to account menu

oxphaman

Known as: 1,4-Benzenediol, 2-((tricyclo(3.3.1.13,7)dec-1-ylimino)methyl)-, 1-(2,5-dihydroxybenzylidene)aminoadamantane 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AdamantaneLipoxygenase Inhibitors
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
[The pharmacology of the lipoxygenase inhibitors oxphaman (1-(2,5-dihydroxybenzylidene)aminoadamantane) and oxphalin (1-(3,4-dihydroxybenzylidene)-2,4,6-trimethylaniline].
Oxphaman and particularly oxphalin, among other phenolic azomethines, have been proven as strong inhibitors of lipoxygenases (LOX… 
1988
1988
Action of cyclooxygenase (COX) and lipoxygenase (LOX) inhibitors as well as of oxygen free radical scavengers (OFRS) in the inflammation-induced vasodepression.
Vasoprotective activity of COX inhibitors (diclofenac, piroxicam, indomethacin, aspirin) and of LOX inhibitors… 
1988
1988
Role of eicosanoids in the kappa-carrageenin rat tail thrombosis.
Pretreatment of rats by the cyclooxygenase inhibitors diclofenac, phenylbutazone, and aminophenazone did not influence kappa… 
1988
1988
[The effect of cyclo-oxygenase and lipoxygenase inhibitors on anaphylactic vasodepression ex vivo in mice and rats].
Cyclooxygenase inhibitors (diclofenac, indomethacin, piroxicam) does not or only hardly inhibit anaphylactic vasodepression… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)